Log in

ASX:OBJOBJ Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
OBJ Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. OBJ Limited was founded in 2004 and is based in Leederville, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostics & Research
Phone61 8 9443 3011



Sales & Book Value

Annual Sales$1.98 million
Book ValueA$0.01 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive OBJ News and Ratings via Email

Sign-up to receive the latest news and ratings for OBJ and its competitors with MarketBeat's FREE daily newsletter.

OBJ (ASX:OBJ) Frequently Asked Questions

Has OBJ been receiving favorable news coverage?

News headlines about OBJ stock have trended somewhat negative on Sunday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. OBJ earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutOBJ.

Who are some of OBJ's key competitors?

Who are OBJ's key executives?

OBJ's management team includes the following people:
  • Mr. Jeffrey David Edwards, Founder, MD, Technical Director & Exec. Director
  • Mr. Paul Peros, Chief Exec. Officer
  • Dr. Matthew McIldowie, Chief Scientific Officer
  • Mr. John Joseph Palermo B.Bus, CA, FCA, ASCA, J.P., ACIS, AGIA, Snr, Company Sec.
  • Dr. Michael Roberts, Scientific Adviser

What is OBJ's stock symbol?

OBJ trades on the ASX under the ticker symbol "OBJ."

How big of a company is OBJ?

OBJ has a market capitalization of $0.00 and generates $1.98 million in revenue each year.

What is OBJ's official website?

The official website for OBJ is www.obj.com.au.

How can I contact OBJ?

The company can be reached via phone at 61 8 9443 3011.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.